Related Experiment Video
Updated: Jan 19, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Transcranial direct current stimulation in patients with obsessive compulsive disorder: A randomized controlled trial
Rémy Bation1, Marine Mondino2, Florent Le Camus2
1INSERM U1028, CNRS UMR5292, PSYR2 Team, Lyon Neuroscience Research Center, Université Claude Bernard Lyon 1, Lyon, France; Centre Hospitalier Le Vinatier, Bron, France; Psychiatric Unit, Wertheimer Neurologic Hospital, CHU Lyon, F69500, Bron, France.
Transcranial direct current stimulation (tDCS) showed short-term improvement for obsessive-compulsive disorder (OCD) symptoms. However, this treatment did not provide significant long-lasting symptom reduction in patients with treatment-resistant OCD.
Area of Science:
- Neuroscience
- Psychiatry
- Neuromodulation
Background:
- Obsessive-compulsive disorder (OCD) is a severe mental health condition with limited treatment options.
- Neuroimaging reveals dysfunction in the orbito-fronto-striatal-pallidal-thalamic network in OCD patients.
- Treatment-resistant OCD necessitates novel therapeutic approaches.
Purpose of the Study:
- To evaluate the efficacy and safety of transcranial direct current stimulation (tDCS) for treatment-resistant OCD.
- To investigate the acute and long-lasting effects of tDCS on OCD symptoms.
- To assess tDCS with specific electrode placements: cathode over the orbitofrontal cortex (OFC) and anode over the right cerebellum.
Main Methods:
- A randomized, sham-controlled, double-blind study involving 21 OCD patients.
- Ten 20-minute tDCS sessions (two per day) of either active (2mA) or sham stimulation.
- Symptom assessment using the Yale-Brown Obsessive and Compulsive Scale (YBOCS) immediately after treatment and at 1- and 3-month follow-ups.
Main Results:
- Active tDCS significantly reduced OCD symptoms immediately after the 10 sessions compared to sham tDCS (p=0.03).
- No significant differences in YBOCS scores or responder rates were found between active and sham groups at 1- and 3-month follow-ups.
- The observed acute effects did not translate into sustained symptom improvement.
Conclusions:
- tDCS applied to the left OFC and right cerebellum demonstrated acute efficacy in reducing OCD symptoms.
- The treatment did not yield statistically significant long-lasting reductions in symptoms for patients with treatment-resistant OCD.
- Further research may be needed to optimize tDCS parameters or identify patient subgroups who benefit from this neuromodulation technique.
Related Concept Videos
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
09:29Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
06:01Transcranial Direct Current Stimulation for Online Gamers
Obsessive-Compulsive Disorder
07:52Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation
11:54Transcranial Direct Current Stimulation (tDCS) in Mice

